Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

Paper Submission

Views	Downloads

Relative Articles
Angiotensin converting enzyme inhibitors in acute myocardial infarction: when to start therapy and which drug to use?
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
Oxidative stress and possibility to correct it with angiotensin converting enzyme inhibitors in patients with myocardial infarction associated with diabetes mellitus type 2
ELIMINATION OF ANGIOTENSIN – CONVERTING ENZIME INHIBITORS BY PERITONEAL DIALISATE
Increased angiotensin-converting enzyme activity in the left ventricle after infarction
Increased angiotensin-converting enzyme activity in the left ventricle after infarction
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Angiotensin II and myocardial infarction
Angiotensin converting enzyme inhibitors and aortic arch obstructive malformations
Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors
More...

Rational Pharmacotherapy in Cardiology 2010

The use of angiotensin converting enzyme inhibitors after myocardial infarction. What do evidence-based medicine data speak for?

S.Yu. Martsevich

Keywords: randomized clinical trials , angiotensin converting enzyme inhibitor , myocardial infarction.

Full-Text Cite this paper Add to My Lib

Abstract:

The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis after myocardial infarction (MI) are described. Different tactics of ACE inhibitors therapy in post MI patients are presented. Approaches to the choice of a specific ACE inhibitor are discussed.

Full-Text